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Purpose:  We  investigated  the  effect  of  ATP  (ATP)  encapsulated  in  liposomes  (ATP-liposomes)  on  the  level  of
inflammation and neuronal death in the retina induced by ischemia reperfusion (IR).
Methods: Primary retinal ganglion cells treated with ATP-liposomes, empty liposomes, and phosphate buffer solution
(PBS) were deprived of oxygen and glucose (OGD) for 6 h in vitro, in an anaerobic chamber. Plates were assessed for the
proportion of necrotic versus apoptotic cells and for cell survival 12 h after OGD. For in vivo experiments, we induced
retinal ischemia by unilateral elevation of intraocular pressure for 1 h by direct corneal canulation. Mice were injected
with liposomes or PBS 24 h before IR, at the time of surgery, and every 24 h until sacrifice. Transmission electron
microscopic analysis was used to identify necrotic and apoptotic cells in ischemic retinas. The changes in expression of
pro-inflammatory genes 24 h post reperfusion were assessed by quantitative reverse transcription polymerase chain
reaction (RT–PCR). Corresponding changes in protein abundances were analyzed by immunohistochemistry. Cell death
was evaluated by direct counting of neurons in the ganglion cell layer (GCL) of flatmounted retinas 7 days post reperfusion.
Results: Treatment with ATP-liposomes increases retinal ganglion cell (RGC) survival and decreases necrotic cell death
following OGD. Injection of ATP-liposomes markedly decreased necrotic cell death in the GCL following retinal
ischemia. The ATP-liposome treatment reduced the expression of pro-inflammatory genes, including that of interleukin
1β (Il1β), interleukin 6 (Il6), tumor necrosis factor (Thf), chemokine (C-C motif) ligand 2 (Ccl2), chemokine (C-C motif)
ligand 5 (Ccl5), chemokine (C-X-C motif) ligand 10 (Cxcl10), intercellular adhesion molecule 1 (Icam1), and nitric oxide
synthase 2 (Nos2), in the retina 24 h after IR and significantly reduced the GCL neuron death rate 7 days after reperfusion.
Conclusions:  ATP-liposome  treatment  of  IR-challenged  neural  tissues  suppressed  necrosis  and  correlated  with  a
significantly reduced level of inflammation and retinal damage.
Retinal ischemia results in a prolonged period of cell
death with a high level of necrosis versus apoptosis at an early
stage of pathology [1-4]. Rather than mere waste disposal, the
clearance of cells that are dying by necrosis facilitates distinct
signaling in the affected tissue. Necrosis of tissue leads to
inflammatory and toxic activation of phagocytes [5-7]. Thus,
the  predominance  of  necrotic  cell  death  could  mediate
additional damage after ischemia-reperfusion (IR) injury. At
the same time, reduced necrosis might be a way to improve
outcome after IR injury.
The magnitude and form assumed by cell death after
ischemia are largely dependent on intracellular levels of ATP
(ATP). Apoptosis is ATP dependent in general, and cell death
fate by apoptosis or necrosis is determined by intracellular
ATP levels [8-10]. In areas where blood flow is limited, there
is rapid exhaustion of intracellular ATP due to insufficient
oxygen  and  rapid  consumption  of  glucose,  inhibiting
apoptosis and inducing necrotic cell death [10,11]. Thus, the
Correspondence  to:  D.  Ivanov,  Bascom  Palmer  Eye  Institute,
Department of Ophthalmology, University of Miami Miller School
of Medicine, 1638 NW 10th Ave, Miami, FL, 33136; Phone: (305)
326-6344; FAX: (305) 547-3718; email: divanov@med.miami.edu
application of exogenous ATP could restore the viability of
ischemic cells. However, the pharmacological use of ATP is
restricted due to poor cellular penetration and rapid hydrolysis
by ectoenzymes [12].
In an attempt to develop a system of protecting ATP
against  degradation  during  delivery,  we  considered  an
encapsulation into multilamellar vesicles (liposomes). The
efficiency of the liposomes encapsulated with ATP (ATP-
liposomes) in preventing cell death and improving the energy
status of cells has been shown in vitro and in vivo [12]. Thus,
the  recovery  of  ATP  stores  delivered  by  ATP-liposomes
would increase the survival of some cells and let others die by
apoptosis  instead  of  necrosis.  Because  necrosis,  unlike
apoptosis, is associated with a release of intracellular contents
and  a  subsequent  inflammatory  reaction,  reduction  in  the
proportion of necrotic death should result in a smaller final
lesion.  In  this  study  we  investigated  the  effect  of  ATP-
liposome injection on the survival of retinal neurons in the
ganglion cell layer (GCL) challenged with IR injury.
METHODS
Animals:  All  experiments  and  post-surgical  care  were
performed  in  compliance  with  the  National  Institutes  of
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2882Health Guide for the Care and Use of Laboratory Animals, the
Association  for  Research  in  Vision  and  Ophthalmology
statement  for  use  of  animals  in  ophthalmic  and  vision
research,  and  according  to  the  University  of  Miami
Institutional  Animal  Care  and  Use  Committee  approved
protocols. All animals used in our experiments were 3-month-
old C57BL/6J (stock number 000664; Jackson Laboratory,
Bar Harbor, ME) male mice or 10–14-day-old pups.
Isolation of retinal ganglion cells: Pups were euthanized by
cervical dislocation, eyes were enucleated, and retinas were
mechanically dissected out. Retinal ganglion cells (RGCs)
were  isolated  according  to  the  two-step  immunopanning
method [13]. Briefly, the whole retinas were incubated in
papain  solution  (16.5  U/ml)  for  30  min.  In  the  next  step
macrophage and endothelial cells were removed from the cell
suspension by panning with the anti-macrophage antiserum
(Accurate Chemical, Westbury, NY). RGCs were specifically
bound to the panning plates containing anti-Thy1.2 antibody
and  released  by  trypsin  incubation.  RGCs  were  grown  in
Neurobasal/B27 media (Invitrogen, Carlsbad, CA).
Oxygen and glucose deprivation model: RGCs treated with
ATP-liposomes,  blank  liposomes  (PC-liposomes),  and
phosphate buffer solution (PBS: 1.4 mM KH2PO4, 8 mM
Na2HPO4, 140 mM NaCl, 2.7 mM KCl, pH 7.4; vehicle) were
deprived of oxygen using an anaerobic chamber (0% O2, 5%
CO2, and 95% N2) and glucose- and sodium pyruvate-free
Neurobasal media (Invitrogen) media for 6 h at 37 °C. After
oxygen  and  glucose  deprivation,  the  culture  medium  was
exchanged for fresh Neurobasal/B27 media, and the neurons
were further incubated for 12 h in a 5% CO2 atmosphere.
Parallel  cultures  were  exposed  to  oxygenated  media  in  a
normoxic incubator (37 °C; atmosphere 5% CO2) to serve as
sham controls.
Transient retinal ischemia: Retinal ischemia was induced for
60 min by introducing into the anterior chamber of the eye a
33-gauge needle attached to a normal (0.9% NaCl) saline-
filled reservoir raised above the animal to increase intraocular
pressure  (IOP;  IOP  increased  to  120  mmHg).  The
contralateral eye was canulated and maintained at normal IOP
to serve as a normotensive control. Body temperature was
maintained  at  37±0.5  °C.  Complete  retinal  ischemia,
evidenced by a whitening of the anterior segment of the eye
and  blanching  of  the  retinal  arteries,  was  verified  by
microscopic examination.
Treatment  with  liposomes:  Liposomes  encapsulated  with
carboxyfluorescein  (CF-liposomes),  ATP-liposomes,  and
PC-liposomes with a diameter of about 100 nm were prepared
by  Encapsula  NanoSciences  (Nashville,  TN).  In  brief,  a
mixture of 12 mM L-[α]-phosphatidylserine (PS) and 33 mM
L-[α]-phosphatidylcholine (PC) in chloroform were placed in
a test tube. The liposomes were composed of either PC only
(PC-liposomes) or a combination of PC and PS at a molar ratio
of 7:3 (PS-liposomes). The solvent was removed in a rotary
evaporator at 30 °C under reduced pressure and then dried by
a desiccator for 1 h. The desiccated lipids were dispersed with
a vortex mixer in PBS (pH 7.4) to obtain a final concentration
of  10  mg/ml  total  lipids.  The  lipid  suspensions  were
subsequently  sonicated  for  10  min  on  ice.  The  liposome
solutions were centrifuged, and then the supernatants were
used for the experiments. Mice were injected intramuscularly
(IM) with either liposomes (0.5 mg [or 13.2 mM] suspension
in PBS per animal) or carrier buffer (PBS) 24 h before IR, at
the time of surgery, and then every 24 h until sacrifice. Retinas
were collected and analyzed 1 or 7 days after IR. We used six
animals in each treated group. For in vitro experiments RGCs
were  treated  with  200  µM  liposomes  during  oxygen  and
glucose deprivation (OGD) and reperfusion at 37 °C.
Neuronal death assay: After OGD, necrotic and apoptotic
cells were determined using the Vybrant Apoptosis Assay Kit
#2 (Invitrogen, Carlsbad, CA). Cells were imaged using a
Leica  TSL  AOBS  SP5  confocal  microscope  (Leica
Microsystems, Exton, PA) and counted using MetaMorph
(Molecular  Devices,  Sunnyvale,  CA)  software.  The
percentage of necrotic cells (annexin V and propidium iodide
[PI]) and apoptotic cells (only annexin V) relative to the total
number of cells was determined for each of ten images.
ATP level in ischemic retina: Animals were perfused with
PBS.  Retinas  were  removed  and  transferred  to  a  1.5-ml
microfuge tube, and 10 µl of ice-cold 0.4 M perchloric acid
was  added  per  milligram  wet  tissue.  The  retinas  were
immediately homogenized with a pellet pestle. The acidic
homogenate was kept on ice for 30 min and then centrifuged
at  16,100×  g  at  4  °C  for  10  min.  The  supernatant  was
neutralized with 10 µl of 4 M K2CO3 added to 100 µl of the
supernatant, kept on ice for 10 min and at −8 °C for 1–2 h to
promote precipitation of the perchlorate, and then centrifuged
again. Supernatants were stored at −8 °C until the luciferase
assay. The ATP concentration was assessed quantitatively by
using the EnzyLight™ ATP Assay Kit (BioAssay Systems,
Hayward, CA) according to the instructions. Briefly, 100 μl
of  a  fivefold  dilution  of  each  sample  was  transferred  in
triplicate into wells of a white opaque 96-well plate (Costar,
Corning,  NY)  and  incubated  for  10  min  with  90  μl  of
reconstituted reagent containing the assay buffer, d-luciferin,
and luciferase (95:1:1). Luminescence was read on a Centro
XS3  LB960  luminometer  (Berthold  Technologies,  Oak
Ridge, TN) with an integration time of 1 s per well. ATP
concentrations  were  extrapolated  from  the  linear  ATP
standard curve.
Transmission  electron  microscopy:  Retinas  with  ischemia
reperfusion were fixed with 2.5% glutaraldehyde in 0.1 M
phosphate buffer (pH 7.4) for 1 h at 25 °C, postfixed with 1%
osmium tetroxide for 1 h at 25 °C, dehydrated through a
graded  alcohol  series,  and  embedded  in  Epon812  resin.
Ultrathin sections (80 nm thick) were cut with an Ultracut S
(Leica, Vienna, Austria) and then stained with uranyl acetate
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sections were observed under a Philips CM-10 transmission
electron  microscope  (FEI  Company,  Hillsboro,  Oregon).
Transmission electron microscopic (TEM) analysis was used
to characterize the cell death mode in the retinas at 24 h after
the  ischemia  reperfusion.  The  numbers  of  necrotic  and
apoptotic cells for these measurements, taken in 10 adjacent
areas (one area, 8×12 μm) within 3 mm of the optic nerve,
were calculated.
Real-time PCR: Real-time PCR analysis was performed using
gene-specific primers (Table 1). Total RNA was extracted
from retinas using Nanoprep (Stratagene, Carlsbad, CA) and
reverse  transcribed  with  Superscript  III  (Invitrogen)
polymerase  to  synthesize  cDNA.  Real-time  PCR  was
performed in the Rotor-Gene 6000 Cycler (Qiagen, Valencia,
CA) using the SYBR GREEN PCR MasterMix (Qiagen). For
each gene, relative expression was calculated by comparison
with  a  standard  curve  following  normalization  to  the
housekeeping  gene  β-actin  (Actb)  expression  chosen  as
control.
Immunohistochemistry:  Fixed  retinas  were  sectioned  to  a
thickness of 100 μm with vibratome (Vibratome, St. Louis,
MO) and immunostained using the protocol described earlier
[13]. Briefly, sections were permeabilized with 0.3% Triton
X-100 in PBS for 45 min, rinsed in PBS and blocked by 5%
donkey serum, 2% BSA and 0.15% Tween-20 in PBS for 1 h
and  incubated  overnight  with  various  primary  antibodies
(Table 1), followed by species-specific secondary fluorescent
antibodies (AlexaFluor; Invitrogen). Control sections were
incubated  without  primary  antibodies.  Imaging  was
performed with a Leica TSL AOBS SP5 confocal microscope
(Leica Microsystems, Exton, PA).
Immunohistochemistry  for  Neuronal  Nuclei  (NeuN)  in
flatmounted retinas: Eyes were enucleated upon euthanasia
by CO2 inhalation under anesthesia, incised at the ora serrata,
immersion fixed in a 4% paraformaldehyde solution (in PBS,
pH 7.4) for 1 h, and the retinas removed. The retinas were
cryoprotected overnight in 30% sucrose followed by 3 freeze–
thaw cycles, rinsed 3×10 min in 0.1 M PBS and blocked by
5% donkey serum, 0.1% Triton X-100 in 0.1 M Tris buffer
(TB)  for  1  h,  and  incubated  overnight  with  monoclonal
fluorescein isothiocyanate (FITC)-conjugated NeuN antibody
(dilution 1:300; Chemicon, Billerica, MA). After 3×10 min
rinses in 0.1 M TB, retinas were flatmounted, coverslipped,
and  imaged  using  a  Leica  TSL  AOBS  SP5  confocal
microscope.
Counting  of  NeuN  positive  ganglion  cell  layer  (GCL)
neurons: NeuN-positive neurons in the GCL, including RGCs
and  displaced  amacrine  cells,  were  imaged  by  confocal
microscopy in flatmounted retinas. Individual retinas were
sampled randomly to collect a total of 20 images located at
the same eccentricity in the four retinal quadrants using a 20×
TABLE 1. LIST OF PCR PRIMERS AND THE PRIMARY ANTIBODIES
Gene Oligonucleotides PCR product size Primary antibodies
Il1b F: GACCTTCCAGGATGAGGACA 283 bp PR-427β (Endogen)
R: AGGCCACAGGTATTTTGTCG
Il6 F: ATGGATGCTACCAAACTGGAT 138 bp AMC0864 (Biosource)
R: TGAAGGACTCTGGCTTTGTCT
Il10 F: GGTTGCCAAGCCTTATCGGA 190 bp
ACCTGCTCCACTGCCTTGCT
Tgfb1 F: TGAGTGGCTGTCTTTTGACG 292 bp
R: TCTCTGTGGAGCTGAAGCAA
Ccl2 F: AGGTCCCTGTCATGCTTCTG 279 bp Sc-1784 (Santa Cruz)
R: ATTTGGTTCCGATCCAGGTT
Ccl5 F: AGCAGCAAGTGCTCCAATCT 280 bp
R: ATTTCTTGGGTTTGCTGTGC
Cxcl10 F: GCTGCAACTGCATCCATATC 293 bp Sc-1406 (Santa Cruz)
R: CACTGGGTAAAGGGGAGTGA
Icam1 F: TGGTGATGCTCAGGTATCCA 273 bp
R: CACACTCTCCGGAAACGAAT
Vcam1 F: GTGGTGCTGTGACAATGACC 287 bp
R: ACGTCAGAACAACCGAATCC
Cybb F: GACTGCGGAGAGTTTGGAAG 277 bp
R: ACTGTCCCACCTCCATCTTG
Nos2 F: CAGAGGACCCAGAGACAAGC 299 bp
R: TGCTGAAACATTTCCTGTGC
Actb F: CACCCTGTGCTGCTCACC 327 bp
R: GCACGATTTCCCTCTCAG
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automatically  using  MetaMorph  (Molecular  Devices,
Sunnyvale, CA) software. Cell loss in the ischemic retinas was
calculated as percentile of the mean cell density in fellow
control eyes.
Statistical analysis: Statistical analysis of real-time PCR and
cell  density  data  was  performed  with  one-way  ANOVA
followed by the Tukey test for multiple comparisons. In case
of single comparisons, the Student t test was applied. P values
equal  to  or  less  than  0.05  were  considered  statistically
significant.
RESULTS
Treatment with ATP-liposomes increases RGC survival and
decreases necrotic cell death following OGD: OGD, a model
of ischemia in vitro, produces a rapid decrease of neuronal
ATP followed by cell death by necrosis and apoptosis [12,
14]. To restore the required level of ATP in ischemic cells,
ATP-liposomes were applied. We induced OGD in cultures
of primary RGCs, which were purified using the two-step
immunopanning protocol. Because ATP is unstable, we used
ATP-liposomes prepared within 24 h for each experiment.
Cultures of primary RGCs were assessed for levels of necrotic
and apoptotic cells and survival after 12 h using annexin V as
a  marker  of  apoptotic  cells  and  annexin  V/PI  to  identify
necrotic cells (Figure 1C). Quantification of cell death was
performed  by  phase-contrast  microscopy  and  showed
significantly higher survival in OGD-exposed cultures treated
by  ATP-liposomes  versus  PC-liposomes  or  PBS  (p<0.01,
Figure 1A). The percentage of necrotic cells was significantly
higher in cultures treated with PC-liposomes or PBS versus
ATP-liposomes (p<0.01, Figure 1B). Thus, treatment with
ATP-liposomes  reduced  OGD  cell  death  by  necrosis  and
increased the level of cell survival.
Treatment  with  ATP-liposomes  reduces  inflammation
following retinal ischemia: It has been shown that liposomes
are efficiently incorporated into the central nervous system
across the blood–brain barrier of normal and post-ischemic
tissues [15]. To investigate liposomal incorporation into the
ischemic retina across the blood–retinal barrier, animals were
IM  injected  with  liposomes  encapsulated  with
carboxyfluorescein (CF-liposomes) 24 h before IR and at the
time of surgery. Retinal IR was induced by unilateral elevation
of  IOP  via  corneal  canulation  with  normotensive  saline.
Retinas were collected and analyzed 24 h after IR. After IM
administration of CF-liposomes, numerous fluorescent cells
were seen in the ischemic retinas (Figure 2A). In addition, the
level  of  ATP  in  ischemic  retinas  treated  with  ATP,  PC-
liposomes,  and  PBS  was  assessed  using  the  ATP
bioluminescent assay. We injected experimental mice IM with
ATP-liposomes  twice:  24  h  before  IR  and  at  the  time  of
surgery. Because ATP is unstable we used ATP-liposomes
prepared within 24 h for each experiment. Control animals
were injected with PC-liposomes at equimolar concentration
or  PBS.  The  contralateral  eye  served  as  a  normotensive
control.  We  did  not  detect  statistically  significant  ATP
depletion in treatment with ATP-liposomes, PC-liposomes,
and PBS ischemic retinas compared to sham-operated retinas
24 h after reperfusion (Figure 2B). However, liposomal ATP
significantly increased the level of ATP in ischemic and sham-
operated  retinas  compared  to  PC-liposomes  and  PBS
Figure 1. ATP-liposomes rescue retinal ganglion cell from necrosis after oxygen and glucose deprivation. A: Treatment by ATP (ATP)-
liposomes results in neuroprotective effects in the retinal ganglion cell (RGC) primary cultures after 6 h of oxygen and glucose deprivation
(OGD) following 12 h re-oxygenation compared to phosphatidylcholine (PC)-liposomes and PBS-treated RGCs; survival rate after OGD is
expressed as a percentage of the mean value obtained in parallel cultures. B: Treatment with ATP-liposomes decreases necrotic cell death in
the RGCs cultures following 6 h OGD and 12 h re-oxygenation. C: Necrotic and apoptotic cells were determined using Annexin V as a marker
of apoptotic cells and Annexin V/propidium iodide (PI) to identify necrotic cells. The percentage of necrotic cells and apoptotic cells relative
to the total number of cells was determined for each of ten images (*p<0.05, **p<0.01).
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2885treatment  (Figure  2B).  Thus,  ATP-liposomes  used  in  our
study effectively pass through the blood–retinal barrier.
Our  in  vitro  experiments  suggest  that  treatment  of
ischemic retinas with ATP-liposomes could reduce necrotic
cell death. To test this hypothesis, we used TEM analysis,
which has been considered a “gold standard” in cell-death
research. Retinal ischemia was induced, and animals were
treated as above. Twenty-four hours after reperfusion, retinas
were collected and used for TEM analysis. Our results suggest
that GCL cells in ischemic retinas treated with PBS and PC-
liposomes  died  predominantly  by  necrosis,  which  was
characterized  by  a  loss  of  electron  density  in  the  cytosol
without nuclear condensation (Figure 3). At the same time,
injection of ATP-liposomes markedly reduced necrotic cell
death in the GCL following retinal ischemia (Figure 3). It
should  be  noted  that  treatment  with  ATP-liposomes
significantly decreased edema in retinas after IR injury (data
not shown).
Necrotic cell death, in contrast to apoptotic cell death,
leads to the release of “danger” signals initiating an innate
immune response. Thus, in tissue treated by ATP-liposomes,
reduced necrotic cell death could contribute to a diminished
inflammatory response in tissue after IR injury. To test this
hypothesis, we analyzed total RNA extracted from the IR-
exposed  retinas  for  the  abundance  of  transcript  for  pro-
inflammatory  genes.  Retinas  were  analyzed  24  h  post
reperfusion because most changes in gene expression for pro-
inflammatory factors typically occur shortly after IR injury.
Transcriptional  upregulation  of  cytokines  (interleukin  1β
[Il1β], interleukin 6 [Il6], and tumor necrosis factor [Thf]),
chemokines  (chemokine  (C-C  motif)  ligand  2  [Ccl2],
chemokine (C-C motif) ligand 5 [Ccl5], and chemokine (C-
X-C  motif)  ligand  10  [Cxcl10]),  intercellular  adhesion
molecule 1 (Icam1), and nitric oxide synthase 2 (Nos2) was
evident in experimental eyes of animals treated with either
ATP-, PC-liposome, or PBS (Figure 4A). However, the level
of activation for these genes, particularly for Il1β, Il6, Tnf,
Ccl5, Cxcl10, Icam1, and Nos2 genes, was significantly lower
in the mice treated with ATP-liposomes versus PC-liposomes
or PBS. As for transforming growth factor beta 1 (Tgfb1),
Ccl2,  vascular  cell  adhesion  molecule  1  (Vcam1),  and
cytochrome  b-245,  beta  polypeptide  (Cybb)  genes,  the
difference between ATP- and PC-liposome treatments was
not statistically significant. These data were confirmed for
Ccl2 and Cxcl10 at the protein accumulation level, as detected
in  ischemic  retina  24  h  after  reperfusion  by
immunohistochemistry (Figure 4B). These results indicate
that  ATP  liposomes  are  more  potent  in  suppressing
inflammatory  pathways  compared  to  PC  liposomes.
Nevertheless, significant suppression of inflammatory genes
was also evident with PC-liposome treatment, the effect that
we and others described earlier [16].
Treatment  with  ATP-liposomes  reduces  neuronal  loss  in
retinal ischemia: IR-induced degeneration of neurons in the
GCL is biphasic with a primary degeneration occurring within
24  h  after  reperfusion  and  a  secondary  degeneration
progressing  over  several  days  [17].  To  detect  cumulative
damage  from  both  waves  of  degeneration,  we  evaluated
Figure 2. ATP-liposomes effectively pass through the blood–retinal barrier. A: Confocal photomicrographs of flatmounted ischemic retinas
treated with carboxyfluorescein (CF)-liposomes or carrier buffer PBS were taken 24 h after ischemia reperfusion (IR). Nonfixed freshly
isolated retinas were visualized by confocal microscopy in the ganglion cell layer (GCL). Retinal GCL cells display green fluorescence,
indicating liposomal uptake (yellow arrows). Punctuate traces of CF labeling are likely endothelial cells in blood capillaries (red arrows).
PBS-treated controls display little autofluorescence. The scale bar represents 50 µm. B: Relative changes in ATP (ATP) content in control
(sham) and ischemic (24 h) retinas following the treatment with ATP, PC- liposomes, and PBS 24 h after reperfusion. The results are shown
as a percentage of the corresponding value in PBS-treated sham-operated retinas (*p<0.05, n=5).
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injected IM with liposomes or PBS 24 h before IR, at the time
of surgery, and then every 24 h. We evaluated neuronal cell
death by measuring the density of neurons labeled with the
neuronal marker NeuN in the GCL in flatmounted retinas. The
percentage of surviving GCL neurons in the IR retinas was
significantly  higher  in  mice  injected  with  ATP-liposomes
(99±1%)  compared  to  those  injected  with  PC-liposomes
(81±3%,  p<0.01,  n=6)  and  PBS  (69±2%,  p<0.001,  n=6;
Figure 5A). The NeuN immunohistochemistry showed that
affected  neurons  were  distributed  evenly,  without  a
geographic pattern, across ischemic retinas in all treatment
groups (Figure 5B,C).
DISCUSSION
In this work we used liposomes as a vehicle for ATP delivery
to retinal cells. We applied ATP-liposomes in vitro and in vivo
to test whether restoration of intracellular ATP levels protects
retinal neurons against IR injury. Our results showed that
treatment with ATP-liposomes resulted in significant increase
in survival of neurons challenged with IR. Such increased
tolerance of inner retinal neurons to IR injury correlated with
increased levels of ATP in the retinas of treated animals and
reduced cell death by necrosis in both cultured cells and in
ischemic retinas. Thus, our results support the hypothesis that
sufficient levels of intracellular ATP delivered by liposomes
protect cells from energy failure caused by IR injury. This is
in  a  good  agreement  with  studies  where  ATP-liposomes
greatly increased the number of ischemic episodes tolerated
before  brain  electrical  silence  and  death  appeared  [18].
Significantly,  it  was  shown  that  ATP-liposomes  can
effectively protect myocardium from IR damage [19,20].
Inflammation is a pathologic hallmark of IR injury that
spatiotemporally correlates to the delayed phase of cell death
[19-22]. At the cellular level, the postischemic inflammatory
Figure 3. ATP-liposomes prevent retinal ischemia-induced necrosis. A: Transmission electron microscopic (TEM) analysis of the ganglion
cell layer (GCL) of sham operated (sham) and ischemic retinas treated with ATP (ATP)-, phosphatidylcholine (PC)-liposomes, and PBS 24
h after reperfusion was used to identify necrotic and apoptotic cells. B: Quantitative comparisons in terms of the cell populations showed
characteristic features of necrotic (closed column) and apoptotic (open column) cells detected by the analysis of the TEM micrographs. Results
represent the mean±standard error of the mean of three to five independent experiments (*p<0.05).
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nonspecific immune system [19-22]. The predominance of
necrotic  cells  and  abundance  of  necrotic  factors  mediate
inflammatory stress, which can be responsible for additional
damage after IR injury. Our results suggest that near-complete
blockade of necrosis in the GCL of animals treated with ATP-
liposomes  correlated  with  a  significant  decrease  in  pro-
inflammatory  gene  expression.  These  included  pro-
inflammatory  cytokines,  chemokines,  cell  adhesion
molecules, and NO synthase. A robust inflammatory response
in  PBS-  and  PC-liposome-treated  control  animals  can
exacerbate the injury-induced stress by over exposing neurons
to neurotoxic levels of Tnf, Il1b, and Il6 cytokines, as shown
previously [23]. The Ccl5 and Cxcl10 chemokines and the cell
adhesion  molecules  Icam1  are  essential  for  immune  cell
activation, attraction, and trafficking across the blood–brain
barrier into the central nervous system under both physiologic
and pathological conditions [24,25]. Decreased activity of
genes encoding these molecules in animals treated with ATP-
liposomes  suggests  that  the  diminished  ability  for
inflammatory  cells  to  infiltrate  the  retina  could  elicit  a
neuroprotective  effect  following  ischemia.  Finally,  an
excessive activity of Nos2, encoding inducible NO-synthase,
is  likely  causing  oxidative  stress.  The  activation  of  this
enzyme is broadly deleterious, and its inhibition was shown
to be neuroprotective [26]. Our analysis of IR-challenged
retinas revealed that gene expression of Nos2 was suppressed
in  the  retina  of  ATP-liposome-treated  animals  relative  to
controls. Thus, reduced level of inflammation in ischemic
retinas treated with ATP-liposomes could affect increased
cumulative survival of GCL neurons. We hypothesize that in
combination  with  developed  antibody  targeting  to  retinal
neurons, ATP-immunoliposome treatment may represent a
perspective new strategy for retinal ischemia.
In conclusion, this work represents the first report on
protection  from  IR  injury  in  the  retina  induced  by  ATP-
liposomes.  Our  results  suggest  that  suppressing  neuronal
necrosis using ATP-liposomes in the IR-challenged neural
tissues  could  promote  a  neuroprotective  environment  and
reduce tissue damage.
Figure  4.  ATP-liposome  treatment  reduces  inflammatory  gene  and  protein  expression  following  ischemia-reperfusion  (IR)  injury  A:
Differential expression of cytokines, chemokines, cell adhesion molecules, and nitric oxide (NO) synthase was assessed in sham-operated
(sham) controls and in the ischemic retinas of ATP (ATP)-, phosphatidylcholine (PC)-liposome-, and PBS-treated animals 24 h after
reperfusion. Gene expression was assessed using real-time PCR in sham-operated controls and experimental retinas following IR. For each
gene, results are expressed as a percentage of corresponding value in the sham-operated eye of PBS-treated animals±standard error of the
mean after normalization to β-actin (*p<0.05, six animals per group). B: Immunohistochemistry for the Il1b, Il6, Ccl2, and Cxcl10 protein
accumulation in post-ischemic retinas of ATP-, PC-liposome-, and PBS-treated mice is consistent with increased levels of the transcripts at
the level of corresponding proteins. Scale bar indicates 100 μm.
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